Memory impairment in myasthenia gravis

In vivo reversal of depolarizing neuromuscular blockade.

Archives internationales de pharmacodynamie et de therapie·1995

Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.

Anesthesia and analgesia·1992

The interactions of ouabain with post-tetanic and facilitatory drug potentiations at cat soleus neuromuscular junctions in vivo.

Neurochemical research·1990

Motor nerve ending disorder in myasthenia gravis.

Neurology·1988

Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin.

Anesthesiology·1986

Pharmacologic excitability of rat motor nerve endings: the effect of adrenalectomy on neostigmine-induced fasciculations.

The Journal of pharmacology and experimental therapeutics·1985

Incident Stroke in the United States and Foreign Born Black Individuals.

Neurology·2026

Two-Year Retention of Benefits After Paired Vagus Nerve Stimulation in Stroke: Follow-Up of the VNS-REHAB Randomized Clinical Trial.

Neurology·2026

Legal Protections to Mitigate Discrimination due to Neurodegenerative Biomarker Status.

Neurology·2026

Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience.

Neurology·2026

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Neurology·2026

Association of Plasma Neurofilament Light Chain With Diagnostic Classification in a Neuromuscular Referral Cohort: A Cross-Sectional Study.

Neurology·2026

Postpartum-onset anti-PM/Scl-positive dermatomyositis-systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report.

Frontiers in medicine·2026

Severe recurrent anaphylaxis: investigating underlying mechanisms beyond IgE-mediated allergy - a case report.

Frontiers in allergy·2026

Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.

Frontiers in immunology·2026

Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).

Frontiers in immunology·2026

Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.

Frontiers in immunology·2026

Successful management of pembrolizumab-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with uterine serous carcinoma: a case report.

Frontiers in immunology·2026

Related Experiment Videos

Memory impairment in myasthenia gravis

Related Concept Videos

In vivo reversal of depolarizing neuromuscular blockade.

Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.

The interactions of ouabain with post-tetanic and facilitatory drug potentiations at cat soleus neuromuscular junctions in vivo.

Motor nerve ending disorder in myasthenia gravis.

Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin.

Pharmacologic excitability of rat motor nerve endings: the effect of adrenalectomy on neostigmine-induced fasciculations.

Incident Stroke in the United States and Foreign Born Black Individuals.

Two-Year Retention of Benefits After Paired Vagus Nerve Stimulation in Stroke: Follow-Up of the VNS-REHAB Randomized Clinical Trial.

Legal Protections to Mitigate Discrimination due to Neurodegenerative Biomarker Status.

Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience.

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Association of Plasma Neurofilament Light Chain With Diagnostic Classification in a Neuromuscular Referral Cohort: A Cross-Sectional Study.

Postpartum-onset anti-PM/Scl-positive dermatomyositis-systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report.

Severe recurrent anaphylaxis: investigating underlying mechanisms beyond IgE-mediated allergy - a case report.

Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.

Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).

Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.

Successful management of pembrolizumab-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with uterine serous carcinoma: a case report.

Related Experiment Videos

Memory impairment in myasthenia gravis

Related Concept Videos

Related Articles